Zacks Research

Zacks Small-Cap Research initiated coverage on Cosmos Health with a $4.50 price target. They highlight the company’s diversified, vertically integrated model, anticipating strong revenue growth driven by high-margin pharmaceuticals, nutraceuticals, telehealth, and AI R&D. The valuation is based on a five-year DCF analysis, factoring in U.S. market expansion, a $300 million financing facility, and digital asset strategy. Zacks also noted positive recent financial performance.